ZEALAND PHARMA A/S

Business Segments Zealand Pharma A/S

Equities

ZEAL

DK0060257814

Biotechnology & Medical Research

Real-time Estimate Cboe Europe Other stock markets 05:55:42 18/05/2026 pm IST			5-day change	1st Jan Change
311.35 ^DKK	+0.24%		-9.87%	-33.02%

15/05	U.S. Futures Down, European Stocks Fall	DJ
15/05	Zealand Pharma A/S commences an Equity Buyback Plan, under the authorization approved on March 26, 2026.	CI

Sales 2025 by Business Segment

© MarketScreener.com See more

Sales 2025 by Geography

© MarketScreener.com See more

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (DKK)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Biological Products
Biotechnology						29Cr	10Cr	34Cr	6.27Cr	921.49Cr
Total Assets						206.76Cr	153.98Cr	198Cr	950.56Cr	1.59TCr
Interest Expense						-40.91L	-5.78Cr	-2.58Cr	-3.4Cr	-2.91Cr
Income Tax Expense						-87.91L	-64.31L	-51.26L	-46.17L	55Cr
CAPEX						-2.21Cr	-1.17Cr	-1.12Cr	-1.01Cr	-3.34Cr
EBT						-102.69Cr	-97Cr	-71Cr	-108.34Cr	700.11Cr
Gross Profit						17Cr	10Cr	32Cr	5.48Cr	921.4Cr
D&A						4.02Cr	10Cr	2.01Cr	2.31Cr	2.4Cr
Operating Income						-105.24Cr	-84Cr	-57Cr	-127.22Cr	695.94Cr
Net Income						-101.81Cr	-120.21Cr	-70Cr	-107.88Cr	645.5Cr

Geographical Revenue Distribution History

Geographical breakdown of sales (DKK)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Switzerland						-	-	-	-	918Cr
Denmark						-	3.5Cr	4.42Cr	6.23Cr	3.49Cr
Total Assets						18Cr	14Cr	14Cr	13Cr	26Cr
United States						24Cr	6.9Cr	40.94L	4L	-
Total Assets						11Cr	2.17Cr	1.3Cr	-	-
Germany						5.3Cr	-	29Cr	-	-
Foreign						-	-	-	-	-

As early as today, start finding the best investment opportunities!